HUT70404A - SULFATED BéTA-GLYCOLIPID DERIVATIVES AS CELL ADHESION INHIBITORS AND PHARMACEUTICAL COMPNS. CONTG. THEM - Google Patents

SULFATED BéTA-GLYCOLIPID DERIVATIVES AS CELL ADHESION INHIBITORS AND PHARMACEUTICAL COMPNS. CONTG. THEM Download PDF

Info

Publication number
HUT70404A
HUT70404A HU9500655A HU9500655A HUT70404A HU T70404 A HUT70404 A HU T70404A HU 9500655 A HU9500655 A HU 9500655A HU 9500655 A HU9500655 A HU 9500655A HU T70404 A HUT70404 A HU T70404A
Authority
HU
Hungary
Prior art keywords
compound
pharmaceutically acceptable
hydrate
solvate
acceptable salt
Prior art date
Application number
HU9500655A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9500655D0 (en
Inventor
Alain Martel
Alejandro A Aruffo
Jacques Banville
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of HU9500655D0 publication Critical patent/HU9500655D0/hu
Publication of HUT70404A publication Critical patent/HUT70404A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HU9500655A 1994-03-04 1995-03-03 SULFATED BéTA-GLYCOLIPID DERIVATIVES AS CELL ADHESION INHIBITORS AND PHARMACEUTICAL COMPNS. CONTG. THEM HUT70404A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20592894A 1994-03-04 1994-03-04

Publications (2)

Publication Number Publication Date
HU9500655D0 HU9500655D0 (en) 1995-04-28
HUT70404A true HUT70404A (en) 1995-10-30

Family

ID=22764246

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9500655A HUT70404A (en) 1994-03-04 1995-03-03 SULFATED BéTA-GLYCOLIPID DERIVATIVES AS CELL ADHESION INHIBITORS AND PHARMACEUTICAL COMPNS. CONTG. THEM

Country Status (15)

Country Link
US (1) US5663151A (OSRAM)
EP (1) EP0671407A2 (OSRAM)
JP (1) JPH0841093A (OSRAM)
KR (1) KR950032258A (OSRAM)
CN (1) CN1112122A (OSRAM)
AU (1) AU1360595A (OSRAM)
CA (1) CA2142154A1 (OSRAM)
CZ (1) CZ49895A3 (OSRAM)
FI (1) FI951001A7 (OSRAM)
HU (1) HUT70404A (OSRAM)
IL (1) IL112756A0 (OSRAM)
NO (1) NO950763L (OSRAM)
PL (1) PL307524A1 (OSRAM)
RU (1) RU95103100A (OSRAM)
ZA (1) ZA95937B (OSRAM)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2255070C (en) 1996-05-16 2006-08-15 Nissin Food Products Co., Ltd. Novel compounds having antiviral activity
US5700458A (en) * 1996-09-20 1997-12-23 Geltex Pharmaceuticals Inc. Acid-functionalized saccharides as polyvalent anti-infectives
DE19700774A1 (de) * 1997-01-13 1998-07-16 Hoechst Ag Antiadhäsive Sulfatid-Mimetika
US7084122B2 (en) 2001-11-21 2006-08-01 Erik Larsen Use of glycosides of mono- and diacyglycerol as anti-inflammatory agents
AU2003249641B2 (en) * 2002-05-16 2009-08-20 Glycomimetics, Inc. Compounds and methods for inhibiting selectin-mediated function
JP2006502986A (ja) * 2002-07-03 2006-01-26 グリコミメティクス， インコーポレイテッド 新脈管形成に関与する医学的状態の診断および治療のための組成物および方法
US20040219158A1 (en) * 2003-05-02 2004-11-04 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
ATE383367T1 (de) * 2003-11-19 2008-01-15 Glycomimetics Inc Spezifischer antagonist sowohl für e- als auch p- selektine
US20050187171A1 (en) * 2003-11-19 2005-08-25 Glycomimetics, Inc. Glycomimetic antagonists for both E-and P-selectins
US7481080B2 (en) * 2004-07-01 2009-01-27 General Electric Company Clothes washer braking method and apparatus
DE102004036213B4 (de) 2004-07-26 2011-02-24 Johannes-Gutenberg-Universität Mainz Nichtglykosidische und nichtpeptidische Selektininhibitoren, deren Herstellung und pharmazeutische Zusammensetzungen
US7534434B2 (en) * 2004-12-28 2009-05-19 The Rockefeller University Glycolipids and analogues thereof as antigens for NK T cells
US7923013B2 (en) * 2004-12-28 2011-04-12 The Rockefeller University Glycolipids and analogues thereof as antigens for NKT cells
WO2006127906A1 (en) * 2005-05-25 2006-11-30 Glycomimetics, Inc. Heterobifunctional compounds for selectin inhibition
ATE528311T1 (de) * 2005-08-09 2011-10-15 Glycomimetics Inc Glycomimetische inhibitoren des pa-il-lectins, pa-iil-lectins oder beider lectine aus pseudomonas
SI1934236T1 (sl) 2005-09-02 2013-02-28 Glycomimetics, Inc. Heterobifunkcionalni inhibitorji pan-selektina
US20090176717A1 (en) * 2006-06-01 2009-07-09 Glycomimetics, Inc. Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
JP5298020B2 (ja) 2006-10-12 2013-09-25 グリコミメティクス， インコーポレイテッド ヘキソースおよびｎ−アセチルヘキソサミンの糖模倣体置換
CA2677747A1 (en) * 2007-02-09 2008-08-21 Glycomimetics, Inc. Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
US8039442B2 (en) 2007-07-18 2011-10-18 Glycomimetics, Inc. Compounds and methods for treatment of sickle cell disease or complications associated therewith
ES2584927T7 (es) 2007-10-16 2020-11-05 Progen Pg500 Series Pty Ltd Derivados de oligosacáridos sulfatados novedosos
US8895510B2 (en) * 2008-04-08 2014-11-25 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
CA2727788A1 (en) * 2008-06-13 2009-12-17 Glycomimetics, Inc. Treatment of cancers of the blood using selected glycomimetic compounds
CN102421441B (zh) * 2009-05-01 2015-04-01 糖模拟物有限公司 E-选择蛋白和cxcr4趋化因子受体的异双功能抑制剂
US8921328B2 (en) 2010-09-14 2014-12-30 Glycomimetics, Inc. E-selectin antagonists
KR102055958B1 (ko) 2011-12-22 2019-12-13 글리코미메틱스, 인크. E-셀렉틴 길항제 화합물, 조성물, 및 이용 방법
CA2891514C (en) 2012-12-07 2020-08-25 Glycomimetics, Inc. Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells
PT3227310T (pt) 2014-12-03 2019-11-06 Glycomimetics Inc Inibidores heterobifuncionais de e-selectinas e recetores de quimiocina cxcr4
CA3009836A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
US11433086B2 (en) 2016-08-08 2022-09-06 Glycomimetics, Inc. Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
CN109890421B (zh) 2016-10-07 2023-10-20 糖模拟物有限公司 高效的多聚体e-选择蛋白拮抗剂
CA3054605A1 (en) 2017-03-15 2018-09-20 Glycomimetics, Inc. Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
JP7275131B2 (ja) 2017-11-30 2023-05-17 グリコミメティクス， インコーポレイテッド 骨髄浸潤リンパ球を動員する方法、およびその使用
AU2018395417B2 (en) 2017-12-29 2023-07-13 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
WO2019173229A1 (en) 2018-03-05 2019-09-12 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1164388A (en) * 1966-06-14 1969-09-17 Shionogi & Co Crystalline Sulfur-Containing Glycolipid and the Production Thereof.
EP0146810A3 (de) * 1983-12-05 1987-05-13 Solco Basel AG Verfahren zur Herstellung von Sphingosinderivaten
DE3683214D1 (de) * 1985-08-13 1992-02-13 Solco Basel Ag Neues verfahren zur herstellung von sphingosinderivaten.
IT1235162B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisosfingolipidi
JPH0317020A (ja) * 1989-06-14 1991-01-25 Nippon Koutai Kenkyusho:Kk 抗ｈｉｖ剤
JP3096305B2 (ja) * 1990-07-17 2000-10-10 ボード オブ リージェンツ オブ ザ ユニバーシティ オブ オクラホマ Ｇｍｐ―１４０に対する糖タンパク質リガンド
DK84691D0 (da) * 1991-05-07 1991-05-07 Karsten Buschard Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
WO1993005803A1 (en) * 1991-09-25 1993-04-01 Genetics Institute, Inc. Anti-inflammatory selectin inhibitors
US5326752A (en) * 1991-11-27 1994-07-05 Glycomed Incorporated Substituted lactose and lactosamine derivatives as cell adhesion inhibitors

Also Published As

Publication number Publication date
ZA95937B (en) 1996-08-06
HU9500655D0 (en) 1995-04-28
CA2142154A1 (en) 1995-09-05
IL112756A0 (en) 1995-05-26
KR950032258A (ko) 1995-12-20
AU1360595A (en) 1995-09-14
EP0671407A3 (OSRAM) 1995-10-25
JPH0841093A (ja) 1996-02-13
US5663151A (en) 1997-09-02
RU95103100A (ru) 1997-03-20
FI951001L (fi) 1995-09-05
FI951001A7 (fi) 1995-09-05
NO950763D0 (no) 1995-02-28
NO950763L (no) 1995-09-05
FI951001A0 (fi) 1995-03-03
CZ49895A3 (en) 1995-12-13
PL307524A1 (en) 1995-09-18
EP0671407A2 (en) 1995-09-13
CN1112122A (zh) 1995-11-22

Similar Documents

Publication Publication Date Title
HUT70404A (en) SULFATED BéTA-GLYCOLIPID DERIVATIVES AS CELL ADHESION INHIBITORS AND PHARMACEUTICAL COMPNS. CONTG. THEM
AU690358B2 (en) Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
US5747463A (en) Malonate derivatives of glycolipids as cell adhesion inhibitors
US5783693A (en) Methods for synthesizing sulfated disaccharide inhibitors of selectins
US5763413A (en) Lewis-associated compound, process for producing the same, and anti-inflammatory
US5830871A (en) Inhibitors of E-, P- and L-selectin binding
JP4553488B2 (ja) カルボキシメチルガラクトース誘導体
HUT74506A (en) Sialyl lewis-x analogues as inhibitors of cellular adhesion
EP0536969A2 (en) Anti-endotoxin compounds
US5854218A (en) Sialyl Lex analogues as inhibitors of cellular adhesion
JPWO2000017216A1 (ja) カルボキシメチルガラクトース誘導体
US5962660A (en) Sialyl Lewis X mimetics incorporating fucopeptides
WO1997014707A1 (en) SIALYL Lex ANALOGUES AS INHIBITORS OF CELLULAR ADHESION
HUT70433A (en) SULFATED BéTA-GLYCOLIPID DERIVATIVES AS CELL ADHESION INHIBITORS AND PHARMACEUTICAL COMPNS. CONTG. THEM
US5264567A (en) GM3 analogous compound
US5220008A (en) Oligosaccharide inhibitors for influenza virus
JP2823358B2 (ja) 免疫抑制性および寛容原性修飾ルイス▲上ｃ▼およびＬａｃＮＡｃ化合物
US5254676A (en) Oligosaccharide inhibitors for influenza virus
Tamura et al. Effect of Protecting Groups and Solvents in Anomeric O-Alkylation of Mannopyranose1
AU2007303858A1 (en) Anticoagulant compounds
US5380829A (en) Thioglycoside analogs of gangliosides
Heskamp et al. Expeditious synthesis of a trisubstrate analogue for α (1→ 3) fucosyltransferase
EP1164140B1 (en) Novel sulfofucosylacylglycerol derivatives and utilization thereof as drugs
Charon et al. Synthesis and in vitro activities of a spacer-containing glycophospholipid ligand of a lipopolysaccharide receptor involved in endotoxin tolerance
JPWO2000052021A1 (ja) 新規なスルホフコシルアシルグリセロール誘導体およびその医薬としての用途

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal